ADAPTIVE BIOTECHNOLOGIES ANNOUNCES UPDATE TO NCCN GUIDELINES® FOR MULTIPLE MYELOMA, STRENGTHENING MRD TESTING RECOMMENDATIONS AND SPECIFICALLY REFERENCING CLONOSEQ®

Reuters · 2d ago

Please log in to view news